Biometrik's LC-MS/MS Capabilities Continue to Grow with Industry Demands

Writer & Editor: Suci Rahma Yani

Biometrik continues to strengthen its bioanalytical capabilities to support the evolving analytical needs of the pharmaceutical industry. Equipped with five LC-MS/MS instruments, Biometrik has validated analytical methods for more than 150 molecules to date, with its method portfolio continuing to expand in response to market demand and the development of new pharmaceutical products.

Through continuous method development and validation, Biometrik supports a broad range of bioanalytical requirements, from single-drug compounds to combination products containing multiple active pharmaceutical ingredients (APIs). Beyond parent drug analysis, Biometrik also supports studies requiring the quantification of active metabolites, enabling the evaluation of drug compounds and their relevant metabolites in biological matrices when required by the study design.

The growing portfolio of validated analytical methods reflects Biometrik's commitment to providing flexible and reliable bioanalytical solutions for diverse pharmaceutical compounds. Each analytical method is developed and validated according to the specific characteristics of the analyte, the requirements of the study, and applicable bioanalytical validation guidelines. This approach helps ensure that analytical procedures are suitable for their intended purpose and can support the generation of reliable data for bioequivalence studies and other pharmaceutical research activities.

As the pharmaceutical industry continues to develop increasingly diverse and complex drug formulations, the demand for specialized bioanalytical methods also continues to grow. Biometrik is committed to expanding its analytical capabilities in line with these needs, including the development of methods for new molecules, combination drugs, and active metabolites. Supported by its LC-MS/MS instrumentation and ongoing technical development, Biometrik aims to provide comprehensive bioanalytical testing services that respond to the evolving needs of pharmaceutical companies and research partners.